Question: Among adults and children with thermal injuries (P), does the use of a wet dressing (honey) (I), compared with dry dressing (SSD cream) (C), change complications, pain, tissue healing, need for advanced medical care, patient satisfaction, rates of fasciotomy (O)? Quality assessment No of patients Effect Quality Importance No of studies Design Risk of bias Inconsistency Indirectness Imprecision Other Wet dressings Dry dressings considerations (honey) (SSD cream) Relative (95% CI) Absolute Mean time to healing (Subrahmanyam 1991, 497) (Better indicated by lower values) 1 randomised trials serious1 no serious inconsistency serious2 serious3 none 52 52 serious2 serious3 none 2/52 (3.8%) 16/52 (30.8%) none 39/43 (90.7%) 3/41 (7.3%) - MD 7.8 lower (8.87 to 6.73 lower) IMPORTANT VERY LOW Adverse events (Subrahmanyam 1991, 497) 1 randomised trials serious1 no serious inconsistency VERY LOW CRITICAL 834 more per 1000 (from 230 more to 1000 VERY more) LOW CRITICAL RR 0.13 (0.03 268 fewer per 1000 to 0.52) (from 148 fewer to 298 fewer) Infection disappeared after 7 days of treatment (Subrahmanyam 1991, 497) 1 randomised trials serious1 no serious inconsistency serious2 serious3 RR 12.40 (4.15 to 37.00) 1 sequence generation unclear, allocation concealment unclear, no blinding of participants (information from Cochrane review) not wet vs dry dressing 3 small sample size 2 1 Question: Among adults and children with thermal injuries (P), does the use of a wet dressing (honey) (I), compared with dry dressing (potato peel) (C), change complications, pain, tissue healing, need for advanced medical care, patient satisfaction, rates of fasciotomy (O)? Quality assessment No of patients Effect Quality Importance No of studies Design Risk of bias Inconsistency Indirectness Imprecision Other Wet dressings considerations (honey) Dry dressings (potato peel) Relative (95% CI) Absolute Mean time to healing (Subrahmanyam 1996, 491) (Better indicated by lower values) 1 randomised trials serious1 no serious inconsistency serious2 serious3 none 50 50 - none 36/40 (90%) 0/42 (0%) RR 76.56 (4.86 to 1206.92) MD 5.8 lower (6.68 IMPORTANT to 4.92 lower) VERY LOW Infection disappeared after 7 days of treatment (Subrahmanyam 1996, 491) 1 randomised trials serious1 no serious inconsistency serious2 serious3 - VERY LOW CRITICAL 1 sequence generation unclear, allocation concealment unclear, no blinding of participants (information from Cochrane review) not wet vs dry dressing 3 small sample size 2 2 Question: Among adults and children with thermal injuries (P), does the use of a wet dressing (topical penetrating antibacterial)) (I), compared with dry dressing ((petrolatum gauze)) (C), change complications, pain, tissue healing, need for advanced medical care, patient satisfaction, rates of fasciotomy (O)? Quality assessment No of patients Effect Quality Importance No of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Wet dressings (topical penetrating antibacterial) Dry dressings (petrolatum gauze) 3/58 (5.2%) 2/112 (1.8%) Relative (95% CI) Absolute Infection rate (Heinrich 1988, 253) 1 observational studies1 serious2 no serious inconsistency no serious indirectness serious3 none RR 2.9 (0.5 34 more per 1000 IMPORTANT to 16.85) (from 9 fewer to VERY 283 more) LOW 1 non-randomized trial no control for confounding 3 small sample size 2 Question: Among adults and children with thermal injuries (P), does the use of a wet dressing (topical non-penetrating antibacterial)) (I), compared with dry dressing ((petrolatum gauze)) (C), change complications, pain, tissue healing, need for advanced medical care, patient satisfaction, rates of fasciotomy (O)? Quality assessment No of patients Effect Quality Importance No of studies Design Risk of bias Inconsistency Wet dressings (topical Dry dressings Other Indirectness Imprecision non-penetrating (petrolatum considerations antibacterial) gauze) Relative (95% CI) Absolute Infection rate (Heinrich 1988, 253) 1 observational studies1 serious2 no serious inconsistency no serious indirectness serious3 none 2/102 (2%) 2/112 (1.8%) RR 1.1 (0.16 to 7.65) 2 more per 1000 IMPORTANT (from 15 fewer to VERY 119 more) LOW 1 non-randomized trial no control for confounding 3 small sample size 2 3